Quarterly Earnings

Ubisoft reports booming Q3 sales fueled by its top franchises, but a major restructuring, job cuts, and a grim profit forecast paint a complex picture.

Datasea's profits are booming despite a revenue drop, as it pivots to high-margin AI and futuristic acoustic tech. Is this a genius move or a risky gamble?

Skycorp Solar reported a 27% revenue surge driven by global expansion, but intense competition and rising costs led to a surprising net loss.

As BJ’s prepares to report Q4 results, investors are watching if a pizza relaunch and new efficiencies can overcome industry-wide cost pressures.

Bio-Techne promotes Steve Crouse to lead its high-growth Diagnostics and Spatial Biology unit, signaling a strategic focus on innovation after a key divestiture.

With triple-digit growth, the firm's partner-led model is dominating the market as companies race to defend against escalating third-party cyber threats.

Exodus reports a surge in users and swap volume for January, defying a market downturn while strategically increasing its Solana treasury holdings.

LiveOne is set to announce three new Fortune 500 partnerships alongside better-than-expected Q3 results, signaling a major push into the enterprise market.

With major conferences ahead, clinical-stage MBX Biosciences aims to impress investors with its promising peptide therapies for endocrine and metabolic disorders.

The defense contractor signals a strategic shift after lost contracts and procurement delays slash its 2027 revenue outlook, even as profits beat expectations.

As OneSpaWorld prepares its Q4 results, all eyes are on the wellness giant as a barometer for luxury travel spending and its tech-driven future.

South Korea's Hugel shatters sales records with a 105% surge in the Americas, signaling a major power shift in the global medical aesthetics market.

Discover how a brand born from cancer research is reshaping skincare with its launch at Ulta Beauty, making advanced biotech formulas accessible to everyone.

AI genomics firm partners with two major US health systems, aiming to accelerate cancer and rare disease diagnostics for 60,000 patients annually.

TruGolf accelerates its stock repurchase program, signaling faith in its future as it unveils new AI-powered tech in a booming indoor golf market.

As Home Depot prepares its year-end report, investors weigh a tough consumer market against the firm's big strategic bets on pro customers and digital tools.

After a stellar 2025, Corpay is hitting the road for key investor conferences. Can it convince the market its impressive growth is just the beginning?

After posting strong preliminary Q4 results, Harvard Bioscience unveils a new strategy to lead the booming organoid and translational science market.

Amid major restructuring and a strategic asset sale, Standard BioTools' upcoming annual results will reveal its progress toward profitability in a tough market.

Investors eye Kontoor Brands' March 3rd report, seeking proof of sustained momentum for Wrangler and Helly Hansen amid a tough consumer market.